American Heart Association - You’re the Cure
WELCOME! PLEASE LOGIN OR SIGN UP

LoginLogin with Facebook

Remember me Forgot Password

Be the Cure, Join Today!

  • Learn about heart-health issues
  • Meet other likeminded advocates
  • Take action and be heard
SIGN UP

Meet "Brave Heart" Asher

by Julie H. on Thursday, May 1, 2014

This week, we've been asking You're the Cure advocates to help grow the number of Mississippi advocates as we prepare to work on our next campaign, pulse ox screenings for newborns.  This simple non-invasive test, when performed on newborns, leads to early diagnosis and treatment of congenital heart defects (CHD), the most common birth defects in the United States and the leading cause of birth defect related deaths in children under one year.  

Will you please click here and invite your family and friends to become part of the cure today?

Your voice is important to help newborns live longer, healthier lives.  Just ask Anna, the mother of three year old "Brave Heart" Asher, a congenital heart disease survivor.  

Asher, was born with a complex CHD called Tetralogy of Fallot with Pulmonary Atresia.  He also had an Atrial Septal Defect and hypoplastic branch pulmonary arteries; seven heart defects total.  During pregnancy, his parents were unaware of Asher's heart defect, so imagine their shock when their sweet baby boy was born fighting for his life.  Although the family resides in Gulfport, Asher courageously endured two open heart surgeries and three heart catheterizations before his first birthday at Children’s Hospital of Philadelphia.  He had his fourth heart catheterization at two years old.  Asher also has developmental delays due to his heart surgeries and a PVL brain injury.  His CHD will require life-long specialized cardiac care, along with heart surgery/procedures, as he grows or develops complications.  

Help us have a strong You're the Cure voice in Mississippi.  It is with a strong voice that we will be able to help newborns with heart defects live longer, healthier lives.